Hybio Pharmaceutical Co., Ltd. (SHE:300199)
23.65
-0.27 (-1.13%)
May 20, 2026, 11:45 AM CST
Hybio Pharmaceutical Employees
Hybio Pharmaceutical had 1,035 employees as of December 31, 2024. The number of employees increased by 140 or 15.64% compared to the previous year.
Employees
1,035
Change (1Y)
140
Growth (1Y)
15.64%
Revenue / Employee
923.22K CNY
Profits / Employee
91.32K CNY
Market Cap
21.13B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 1,035 | 140 | 15.64% |
| Dec 31, 2023 | 895 | -80 | -8.21% |
| Jan 1, 2023 | 975 | 90 | 10.17% |
| Jan 1, 2022 | 885 | -56 | -5.95% |
| Dec 31, 2020 | 941 | -118 | -11.14% |
| Jan 1, 2019 | 1,059 | 203 | 23.71% |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tasly Pharmaceutical Group | 10,563 |
| Zhejiang Huahai Pharmaceutical | 9,065 |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6,003 |
| Jilin Aodong Pharmaceutical Group | 5,461 |
| Chengdu Kanghong Pharmaceutical Group | 4,470 |
| Kangmei Pharmaceutical | 4,233 |
| Walvax Biotechnology | 1,981 |
| Betta Pharmaceuticals | 1,785 |